News & Research

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June 8, 2023
Lucid
News
Powerful D.C. Republicans Drive Psychedelic Research Efforts
Read more
May 26, 2023
Politico
News
K Street warms up to psychedelics
Read more
May 2, 2023
Globenewswire
News
American Medical Association to Issue First New Code for Psychedelic Therapies
Read more
April 17, 2023
Psychedelics Today
News
The Psychedelic Medicine PAC: The Push for Federal Funding
Read more
April 14, 2023
MindMed
Research
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
Read more
April 13, 2023
The Green Rush Podcast
News
Melissa Lavasani, Founder and CEO of Psychedelic Medicine Coalition
Read more
March 31, 2023
Politico
News
Psychedelics coalition grows its advocacy footprint
Read more
March 23, 2023
Microdose
News
Psychedelic Medicine PAC (Political Action Committee) Launches in Washington
Read more
March 21, 2023
Benzinga
News
New Psychedelic Medicine PAC Will Lobby For Advancing Research In Congress
Read more
March 21, 2023
High Times
News
Psychedelic Medicine PAC
Read more
March 20, 2023
The Hill
News
Psychedelic Medicine PAC seeks to elect leaders who support pro-psilocybin reforms
Read more
March 20, 2023
NBC News
News
Candidates who support psychedelics as medicine get a political action committee
Read more
March 20, 2023
The Washington Times
News
Psychedelic medicine advocates launch PAC to lobby lawmakers
Read more
March 15, 2023
Johns Hopkins University
Research
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Read more
March 8, 2023
Reason For Hope
News
Breakthrough Therapies Act
Read more
March 7, 2023
Marijuana Moment
News
Cory Booker And Rand Paul File Revised Bill To Reschedule Psychedelic Breakthrough Therapies
Read more
March 6, 2023
Psychedelic Spotlight
News
Can Psychedelics Treat Alcohol Use Disorder? Here's What Research Says
Read more
March 3, 2023
High Times
News
Michigan City Decriminalizes Psilocybin, Other Psychedelics
Read more
March 1, 2023
Johns Hopkins University
Research
The costs and benefits of psychedelics on cognition and mood
Read more
February 27, 2023
New York Post
News
Psychedelics could transform cigarette addiction treatment: ‘Metamorphosis’
Read more
February 27, 2023
High Times
News
Study: More Mystical Psychedelic Experiences Linked to Mental Health Improvements
Read more
February 15, 2023
Psychedelic Alpha
News
Psychedelic Research Bulletin: January 2023
Read more
December 9, 2022
NYU Center for Psychedelic Medicine
Research
Psilocybin Therapy in Advanced Cancer
Read more
November 8, 2022
NYU Center for Psychedelic Medicine
Research
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Read more
August 24, 2022
Johns Hopkins University
Research
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying
Read more
August 24, 2022
NYU Center for Psychedelic Medicine
Research
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Read more
July 6, 2022
Multidisciplinary Association for Psychedelic Studies
Research
MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
Read more
June 30, 2022
Ohio State University
Research
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
Read more
June 29, 2022
Multidisciplinary Association for Psychedelic Studies
Research
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD
Read more
March 28, 2022
Johns Hopkins University
Research
A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities
Read more
February 15, 2022
Johns Hopkins University
Research
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Read more
January 11, 2022
Marijuana Moment
News
Global Coalition Launches Push To Reschedule Psilocybin Under International Rules
Read more
May 10, 2021
NYU Center for Psychedelic Medicine
Research
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Read more
November 4, 2020
Johns Hopkins University
Research
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Read more
January 22, 2020
Johns Hopkins University & Ohio State University
Research
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Read more
Newsletter

Sign up with your email address to receive weekly news and updates from Psychedelic Medicine Advocacy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Mission

Psychedelic Medicine Advocacy seeks to educate, advocate, and support research on therapeutic psychedelics for improved mental health and well-being.

Get in Touch
Donate
About UsGet InvolvedNews & ResearchContactDonate

Paid for by Psychedelic Medicine Advocacy.

Psychedelic Medicine Advocacy is a nonprofit organization formed under Section 501(c)(4) of the Internal Revenue Code.
Contributions or gifts to Psychedelic Medicine Advocacy are not deductible as charitable contributions for Federal income tax purposes.
No goods or services are given in exchange for any contribution.